5. Topotecan Injection 4 mg/4 mL (1 mg/mL) from Teva
Teva Pharmaceuticals has initiated a voluntary recall of lot 31328962B of Topotecan Injection 4 mg/4 mL (1 mg/mL), to the retail/institutional level in the United States. This voluntary recall was initiated based on a complaint received from a pharmacy after a single glass particle was observed inside one vial.
The administration of an injectable product that contains particulate matter may result in local irritation or swelling in response to the foreign material. If the particulate matter reaches the blood vessels it can travel to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death. While the health hazard risk could be severe if particulate matter is infused, Teva's internal health assessment determined that the likelihood of patient exposure to impacted products is remote or unlikely. To date Teva has received no further complaints or reports of illness or injury.
Thank you for reading until the last page! We would love to hear your opinions and feedback. Click the thumbs-up below and type in what you want us to know. Alternatively, you could shoot an email to [email protected].
¿Fue útil esta página ¡Danos un pulgar hacia arriba!
